{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:50:09Z","timestamp":1791503409802,"version":"4.3.4"},"reference-count":148,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmig.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Minimally Invasive Gynecology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jmig.2026.06.015","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T14:39:23Z","timestamp":1782052763000},"page":"1422-1431.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Interleukin-6 Levels in Endometriosis and Endometriosis-Associated Ovarian Cancer: A Systematic Review and Meta-Analysis Demonstrating a Biological Gradient"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8703-2587","authenticated-orcid":false,"given":"John J.","family":"Cot\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8954-4028","authenticated-orcid":false,"given":"Remington D.","family":"Cot\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5139-6167","authenticated-orcid":false,"given":"Keara","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7102-0357","authenticated-orcid":false,"given":"Matthew S.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-3763","authenticated-orcid":false,"given":"Robin","family":"Farias-Eisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8801-9886","authenticated-orcid":false,"given":"Ryan W.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4237-476X","authenticated-orcid":false,"given":"Lesley B.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmig.2026.06.015_bib0001","series-title":"Endometriosis","year":"2023"},{"key":"10.1016\/j.jmig.2026.06.015_bib0002","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/amajethics.2025.104","article-title":"Using policy and law to help reduce endometriosis diagnostic delay","volume":"27","author":"Penzer","year":"2025","journal-title":"AMA J Ethics"},{"key":"10.1016\/j.jmig.2026.06.015_bib0003","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/humrep\/deae298","article-title":"Association between endometriosis and working life among Danish women","volume":"40","author":"R\u00f8ssell","year":"2025","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmig.2026.06.015_bib0004","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jmig.2026.06.015_bib0005","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jama.2024.9210","article-title":"Endometriosis typology and ovarian cancer risk","volume":"332","author":"Barnard","year":"2024","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.jmig.2026.06.015_bib0006","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GCO.0000000000001043","article-title":"Atypical endometriosis and the progression to endometriosis-associated ovarian cancer: an updated review","volume":"37","author":"Voigt","year":"2025","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0007","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","article-title":"Cancer-associated mutations in endometriosis without cancer","volume":"376","author":"Anglesio","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0008","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12958-025-01471-3","article-title":"Macrophages in endometriosis: key roles and emerging therapeutic opportunities\u2014a narrative review","volume":"23","author":"Wang","year":"2025","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1657605","article-title":"Dysfunction of natural killer cells promotes immune escape and disease progression in endometriosis","volume":"16","author":"Jiang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0010","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3390\/biom13081253","article-title":"Endometriosis-associated ovarian carcinomas: how PI3K\/AKT\/mTOR pathway affects their pathogenesis","volume":"13","author":"Driva","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jmig.2026.06.015_bib0011","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.3390\/cancers16244187","article-title":"Interleukin-6 modulation in ovarian cancer necessitates a targeted strategy: from the approved to emerging therapies","volume":"16","author":"Amer","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmig.2026.06.015_bib0012","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jmig.2024.02.011","article-title":"Serum levels of interleukins in endometriosis patients: a systematic review and meta-analysis","volume":"31","author":"Werdel","year":"2024","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0013","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3390\/jpm11121335","article-title":"Elevated interleukin-6 levels in the circulation and peritoneal fluid of patients with ovarian cancer as a potential diagnostic biomarker: a systematic review and meta-analysis","volume":"11","author":"Amer","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0014","article-title":"Diagnostic accuracy of interleukin-6 in multiple diseases: an umbrella review of meta-analyses","volume":"10","author":"Han","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jmig.2026.06.015_bib0015","first-page":"226","article-title":"Interleukin-6 as a useful predictor of endometriosis-associated infertility: a systematic review","volume":"17","author":"Incognito","year":"2023","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.jmig.2026.06.015_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156073","article-title":"Meta-analyses reveal serum or plasma Interleukin-6 as a biomarker for malignant ovarian neoplasia","volume":"161","author":"Pa\u0219ca","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.jmig.2026.06.015_bib0017","article-title":"New insights about endometriosis-associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and treatment","volume":"14","author":"Chen","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0018","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jmig.2026.06.015_bib0019","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cyto.2015.01.035","article-title":"Plasma immune analytes in patients with epithelial ovarian cancer","volume":"73","author":"Block","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jmig.2026.06.015_bib0020","series-title":"WebPlotDigitizer [Computer Program]. Version 4.8","author":"Rohatgi","year":"2025"},{"key":"10.1016\/j.jmig.2026.06.015_bib0021","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0022","series-title":"Oxford Centre for Evidence-Based Medicine: Levels of Evidence (March 2009)","author":"Phillips","year":"2009"},{"key":"10.1016\/j.jmig.2026.06.015_bib0023","series-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses","author":"Wells","year":"2000"},{"key":"10.1016\/j.jmig.2026.06.015_bib0024","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108602","article-title":"A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)","volume":"186","author":"Higgins","year":"2024","journal-title":"Environ Int"},{"key":"10.1016\/j.jmig.2026.06.015_bib0026","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4082\/kjfm.23.0034","article-title":"RoBANS 2: a revised risk of bias assessment tool for nonrandomized studies of interventions","volume":"44","author":"Seo","year":"2023","journal-title":"Korean J Fam Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0027","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.jmig.2026.06.015_bib0028","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0029","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jmig.2026.06.015_bib0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0031","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"Downes","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jmig.2026.06.015_bib0032","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jmig.2026.06.015_bib0033","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jmig.2026.06.015_bib0034","series-title":"Statistical inference","author":"Casella","year":"2002"},{"key":"10.1016\/j.jmig.2026.06.015_bib0035","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1002\/sim.3427","article-title":"Meta-analysis of skewed data: combining results reported on log-transformed or raw scales","volume":"27","author":"Higgins","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0036","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0002-9378(91)90582-C","article-title":"Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer","volume":"164","author":"Berek","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0037","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L","article-title":"Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer","volume":"72","author":"Moradi","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jmig.2026.06.015_bib0038","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ijc.2910570305","article-title":"Interleukin-6 serum levels in patients with gynecological tumors","volume":"57","author":"Scambia","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmig.2026.06.015_bib0039","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/1097-0142(19940401)73:7<1882::AID-CNCR2820730718>3.0.CO;2-R","article-title":"Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer","volume":"73","author":"Plante","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.jmig.2026.06.015_bib0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0028-2243(94)90152-X","article-title":"Concomitant measurements of interleukin-6 (IL-6) in serum and peritoneal fluid of patients with benign and malignant ovarian tumors","volume":"56","author":"Schr\u00f6der","year":"1994","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0041","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/bjc.1995.71","article-title":"Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer","volume":"71","author":"Scambia","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmig.2026.06.015_bib0042","first-page":"279","article-title":"Angiogenin, interleukins, and growth-factor levels in serum of patients with ovarian cancer: correlation with angiogenesis","volume":"2","author":"Chopra","year":"1996","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.jmig.2026.06.015_bib0043","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/gyno.1997.4726","article-title":"Serum evaluation of interleukin 6 in ovarian cancer patients","volume":"66","author":"Tempfer","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0044","first-page":"229","article-title":"Serum haptoglobin, CA 125 and interleukin 6 levels in malignant and non-malignant tumors of the ovary","volume":"47","author":"Dobryszycka","year":"1999","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.jmig.2026.06.015_bib0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1525-1438.2000.00003.x","article-title":"Cytokines IL-1\u03b2, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF\u03b1 in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel","volume":"10","author":"Penson","year":"2000","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jmig.2026.06.015_bib0046","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/humrep\/deg321","article-title":"Serum and cyst fluid levels of interleukin (IL)-6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours","volume":"18","author":"Darai","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmig.2026.06.015_bib0047","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2005-01-0160","article-title":"Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia","volume":"106","author":"Maccio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jmig.2026.06.015_bib0048","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1055-9965.EPI-04-0404","article-title":"Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer","volume":"14","author":"Gorelik","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jmig.2026.06.015_bib0049","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/cncr.21147","article-title":"Psychosocial factors and interleukin-6 among women with advanced ovarian cancer","volume":"104","author":"Costanzo","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jmig.2026.06.015_bib0050","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1158\/1078-0432.CCR-06-1828","article-title":"Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: a potential role for interleukin 7","volume":"13","author":"Lambeck","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmig.2026.06.015_bib0051","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1111\/j.1582-4934.2008.00408.x","article-title":"Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients","volume":"13","author":"Macci\u00f2","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0052","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.clinbiochem.2008.01.019","article-title":"Cytokine elevations in acute coronary syndrome and ovarian cancer: a mechanism for the up-regulation of the acute phase proteins in these different disease etiologies","volume":"41","author":"Kavsak","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jmig.2026.06.015_bib0053","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2007.14.1978","article-title":"Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients","volume":"26","author":"Lutgendorf","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0054","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ygyno.2008.09.043","article-title":"A serum based analysis of ovarian epithelial tumorigenesis","volume":"112","author":"Nolen","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2009.03.028","article-title":"p53 autoantibodies, cytokine levels and ovarian carcinogenesis","volume":"114","author":"Tsai-Turton","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004599","article-title":"Development and preliminary evaluation of a multivariate index assay for ovarian cancer","volume":"4","author":"Amonkar","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jmig.2026.06.015_bib0057","first-page":"375","article-title":"Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors","volume":"31","author":"Nowak","year":"2010","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.jmig.2026.06.015_bib0058","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00432-009-0755-5","article-title":"Phase II biomarker trial of a multimarker diagnostic for ovarian cancer","volume":"136","author":"Edgell","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0059","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1111\/j.1582-4934.2009.00911.x","article-title":"Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression","volume":"14","author":"Napoletano","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0060","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1158\/1055-9965.EPI-10-1180","article-title":"Circulating inflammation markers and risk of epithelial ovarian cancer","volume":"20","author":"Clendenen","year":"2011","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.jmig.2026.06.015_bib0061","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","article-title":"Interleukin-6 as a therapeutic target in human ovarian cancer","volume":"17","author":"Coward","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmig.2026.06.015_bib0062","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1158\/1078-0432.CCR-10-3314","article-title":"IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer","volume":"17","author":"Anglesio","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmig.2026.06.015_bib0063","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5152\/jtgga.2011.54","article-title":"Determination of serum CRP, VEGF, Leptin, CK-MB, CA-15-3 and IL-6 levels for malignancy prediction in adnexal masses","volume":"12","author":"\u015een","year":"2011","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"10.1016\/j.jmig.2026.06.015_bib0064","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bbi.2012.04.003","article-title":"Sleep disturbance, cytokines, and fatigue in women with ovarian cancer","volume":"26","author":"Clevenger","year":"2012","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jmig.2026.06.015_bib0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1479-5876-10-45","article-title":"Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women","volume":"10","author":"Autelitano","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0066","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1684\/ecn.2013.0340","article-title":"Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer","volume":"24","author":"Dobrzycka","year":"2013","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jmig.2026.06.015_bib0067","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1177\/1933719112466299","article-title":"Immune response evaluation through determination of type 1, type 2, and type 17 patterns in patients with epithelial ovarian cancer","volume":"20","author":"C\u00e2ndido","year":"2013","journal-title":"Reprod Sci"},{"key":"10.1016\/j.jmig.2026.06.015_bib0068","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1158\/1055-9965.EPI-14-1279-T","article-title":"Inflammatory markers and risk of epithelial ovarian cancer by tumor subtypes: the EPIC cohort","volume":"24","author":"Ose","year":"2015","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.jmig.2026.06.015_bib0069","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4238\/gmr.15027936","article-title":"Effects of the balance between type 1 and type 2 T helper cells on ovarian cancer","volume":"15","author":"Hao","year":"2016","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.jmig.2026.06.015_bib0070","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2873030","article-title":"Markers of oxidative stress and inflammation in ascites and plasma in patients with platinum-sensitive, platinum-resistant, and platinum-refractory epithelial ovarian cancer","volume":"2017","author":"Cant\u00f3n-Romero","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jmig.2026.06.015_bib0071","first-page":"3673","article-title":"Inflammatory and nutritional serum markers as predictors of peri-operative morbidity and survival in ovarian cancer","volume":"37","author":"Kumar","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jmig.2026.06.015_bib0072","first-page":"33","article-title":"Serum expression level of cytokine and chemokine correlates with progression of human ovarian cancer","volume":"38","author":"Luo","year":"2017","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0073","first-page":"101","article-title":"Clinical significance of serum tumor markers CA153, CA125, CA72-4 and FIB, IL-6 levels detection in ovarian cancer","volume":"24","author":"Liu","year":"2018","journal-title":"J Hainan Med Univ"},{"key":"10.1016\/j.jmig.2026.06.015_bib0074","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1186\/s12885-019-6321-x","article-title":"CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress","volume":"19","author":"Shi","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jmig.2026.06.015_bib0075","first-page":"32","article-title":"A study on changes and clinical significance of blood glucose, blood lipid and inflammation in patients with ovarian cancer","volume":"30","author":"Li","year":"2019","journal-title":"J BUON"},{"key":"10.1016\/j.jmig.2026.06.015_bib0076","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13309","article-title":"IL6, IL8, and IL10 in the distinction of malignant ovarian neoplasms and endometriomas","volume":"84","author":"Crispim","year":"2020","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0077","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75536-1","article-title":"Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma","volume":"10","author":"Yabuno","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmig.2026.06.015_bib0078","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1715064","article-title":"Prognostic and clinical value of interleukin 6 and CD45+ CD14+ inflammatory cells with PD-L1+\/PD-L2+ expression in patients with different manifestation of ovarian cancer","volume":"2020","author":"Wertel","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jmig.2026.06.015_bib0079","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ygyno.2020.09.025","article-title":"Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors","volume":"159","author":"Landolfo","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0080","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/s41598-020-59009-z","article-title":"Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer","volume":"10","author":"Kampan","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmig.2026.06.015_bib0081","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/1354750X.2020.1783574","article-title":"Serum cytokines and CXCR2: potential tumour markers in ovarian neoplasms","volume":"25","author":"Micheli","year":"2020","journal-title":"Biomarkers"},{"key":"10.1016\/j.jmig.2026.06.015_bib0082","doi-asserted-by":"crossref","first-page":"8124","DOI":"10.1039\/D0RA10200H","article-title":"A high-performance microfluidic detection platform to conduct a novel multiple-biomarker panel for ovarian cancer screening","volume":"11","author":"Wu","year":"2021","journal-title":"RSC Adv"},{"key":"10.1016\/j.jmig.2026.06.015_bib0083","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/diagnostics11071298","article-title":"Decrease in neutrophil-to-lymphocyte ratio during neoadjuvant chemotherapy as a predictive and prognostic marker in advanced ovarian cancer","volume":"11","author":"Sanna","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.jmig.2026.06.015_bib0084","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/diagnostics11091625","article-title":"The clinical importance of IL-6, IL-8, and TNF-\u03b1 in patients with ovarian carcinoma and benign cystic lesions","volume":"11","author":"Pawlik","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.jmig.2026.06.015_bib0085","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/bios12060412","article-title":"Two biosensors for the determination of interleukin-6 in blood plasma by array SPRi","volume":"12","author":"Szymanska","year":"2022","journal-title":"Biosensors"},{"key":"10.1016\/j.jmig.2026.06.015_bib0086","first-page":"70","article-title":"Validity of estimation of IL-6 level over cancer antigen-125 (CA-125) with sonographic criteria in the prediction of ovarian cancer in patients with adnexal mass","volume":"3","author":"Ali","year":"2022","journal-title":"Al-Azhar Intern Med J"},{"key":"10.1016\/j.jmig.2026.06.015_bib0087","first-page":"1659","article-title":"Effect of serum level of human epididymis protein 4 and interleukin-6 as biomarkers in patients with adnexal mass","volume":"77","author":"Hameed","year":"2022","journal-title":"Arch Razi Inst"},{"key":"10.1016\/j.jmig.2026.06.015_bib0088","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/bios13020279","article-title":"A multiple-array SPRi biosensor as a tool for detection of gynecological\u2013oncological diseases","volume":"13","author":"Szymanska","year":"2023","journal-title":"Biosensors"},{"key":"10.1016\/j.jmig.2026.06.015_bib0089","first-page":"3117","article-title":"Effect of the treatment stage on the serum levels of selected cytokines and antioxidant enzymes in patients with tumors of the reproductive organs","volume":"27","author":"Wieder-Huszla","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jmig.2026.06.015_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292282","article-title":"The role of interleukin 6 (IL6), cancer antigen\u2014125 (CA-125), and human epididymis protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients","volume":"18","author":"Muhammad","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jmig.2026.06.015_bib0091","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1055\/s-0043-1772590","article-title":"Systemic inflammatory patterns in ovarian cancer patients: analysis of cytokines, chemokines, and microparticles","volume":"45","author":"Santiago","year":"2023","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.jmig.2026.06.015_bib0092","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/jpm13060980","article-title":"Comparison of interleukin-6 with other markers in diagnosis of ovarian cancer","volume":"13","author":"Bizo\u0144","year":"2023","journal-title":"J Pers Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0093","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.3390\/cancers15215267","article-title":"A novel predictive multi-marker test for the pre-surgical identification of ovarian cancer","volume":"15","author":"Stephens","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmig.2026.06.015_bib0094","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.bbi.2023.12.014","article-title":"The biology of hope: inflammatory and neuroendocrine profiles in ovarian cancer patients","volume":"116","author":"Lutgendorf","year":"2024","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jmig.2026.06.015_bib0095","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.62347\/GSRD2580","article-title":"Predict value of tumor markers combined with interleukins for therapeutic efficacy and prognosis in ovarian cancer patients","volume":"14","author":"Cheng","year":"2024","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jmig.2026.06.015_bib0096","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.3390\/cancers17142325","article-title":"Divergent immune\u2013metabolic profiles in endometriosis and ovarian cancer: a cross-sectional analysis","volume":"17","author":"Neri","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmig.2026.06.015_bib0097","first-page":"42","article-title":"Diagnostic significance of cytokines in benign and malignant ovarian neoplasms","volume":"2","author":"Garnikovich","year":"2025","journal-title":"Prof Res Healthc"},{"key":"10.1016\/j.jmig.2026.06.015_bib0098","first-page":"10","article-title":"Interleukin-6 and soluble interleukin-6 receptor in peritoneal fluid and serum of patients with endometriosis","volume":"23","author":"Schr\u00f6der","year":"1996","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0099","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0015-0282(98)00204-0","article-title":"The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production","volume":"70","author":"Pellicer","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2026.06.015_bib0100","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/humrep\/17.2.426","article-title":"Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial","volume":"17","author":"Bedaiwy","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmig.2026.06.015_bib0101","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000066291","article-title":"Laparoscopic surgery for the management of ovarian endometrioma","volume":"54","author":"Yoshida","year":"2002","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jmig.2026.06.015_bib0102","first-page":"32","article-title":"Analysis of an interleukin-6 gene promoter polymorphism in women with endometriosis polymorphism in women with endometriosis by pyrosequencing","volume":"10","author":"Wieser","year":"2003","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.jmig.2026.06.015_bib0103","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/humrep\/deh312","article-title":"Use of the concomitant serum dosage of CA 125, CA 19-9 and interleukin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions","volume":"19","author":"Somigliana","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmig.2026.06.015_bib0104","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/humrep\/del419","article-title":"Serum interleukin-6 levels are elevated in women with minimal\u2013mild endometriosis","volume":"22","author":"Martinez","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmig.2026.06.015_bib0105","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1447-0756.2007.00569.x","article-title":"Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis","volume":"33","author":"Kalu","year":"2007","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.jmig.2026.06.015_bib0106","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2007.05.014","article-title":"Panel of markers can accurately predict endometriosis in a subset of patients","volume":"89","author":"Seeber","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jmig.2026.06.015_bib0107","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-0897.2008.00644.x","article-title":"Immune status, psychosocial distress and reduced quality of life in infertile patients with endometriosis","volume":"60","author":"Siedentopf","year":"2008","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0108","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejogrb.2007.05.001","article-title":"Serum cytokines as biomarkers for nonsurgical prediction of endometriosis","volume":"137","author":"Othman","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000119091","article-title":"Serum soluble CD163 and interleukin-6 levels in women with ovarian endometriomas","volume":"66","author":"Jee","year":"2008","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jmig.2026.06.015_bib0110","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/humrep\/dep425","article-title":"Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers","volume":"25","author":"Mihalyi","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmig.2026.06.015_bib0111","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejogrb.2010.10.008","article-title":"The value of serological markers in the diagnosis and prognosis of endometriosis: a prospective case\u2013control study","volume":"154","author":"Socolov","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0112","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.atherosclerosis.2011.08.005","article-title":"Increased asymmetric dimethylarginine and enhanced inflammation are associated with impaired vascular reactivity in women with endometriosis","volume":"219","author":"Kinugasa","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jmig.2026.06.015_bib0113","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jri.2012.06.001","article-title":"Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6","volume":"95","author":"Carmona","year":"2012","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0114","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.mefs.2012.06.002","article-title":"Role of some biomarkers in chronic pelvic pain for early detection of endometriosis in infertile women","volume":"17","author":"Foda","year":"2012","journal-title":"Middle East Fertil Soc J"},{"key":"10.1016\/j.jmig.2026.06.015_bib0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5114\/ceji.2013.35204","article-title":"Experimental immunology non-invasive diagnosis of endometriosis based on a combined analysis of four plasma biomarkers","volume":"38","author":"Yagmur","year":"2013","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0116","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5114\/ceji.2013.39768","article-title":"Serum cytokine and growth factor levels in patients with endometriosis","volume":"38","author":"Kubatova","year":"2013","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0117","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00404-013-2822-z","article-title":"Combination of non-invasive and semi-invasive tests for diagnosis of minimal to mild endometriosis","volume":"288","author":"Elgafor el Sharkwy","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jmig.2026.06.015_bib0118","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/det087","article-title":"Do endometriomas induce an inflammatory reaction in nearby follicles?","volume":"28","author":"Op\u00f8ien","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmig.2026.06.015_bib0119","first-page":"280","article-title":"A comparison between serum levels of interleukin-6 and CA125 in patients with endometriosis and normal women","volume":"29","author":"Kashanian","year":"2015","journal-title":"Med J Islam Repub Iran"},{"key":"10.1016\/j.jmig.2026.06.015_bib0120","first-page":"793","article-title":"The value of CA-125, CA 19-9, interleukin-6, interleukin-8 and HSCRP in the diagnosis of endometriosis","volume":"31","author":"S\u00fctc\u00fc","year":"2015","journal-title":"Acta Med Mediterr"},{"key":"10.1016\/j.jmig.2026.06.015_bib0121","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cyto.2015.08.007","article-title":"Peripheral blood proinflammatory response in women during menstrual cycle and endometriosis","volume":"76","author":"Sikora","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jmig.2026.06.015_bib0122","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijgo.2016.01.018","article-title":"Interleukin-6, intracellular adhesion molecule-1, and glycodelin A levels in serum and peritoneal fluid as biomarkers for endometriosis","volume":"134","author":"Mosbah","year":"2016","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jmig.2026.06.015_bib0123","article-title":"Limited value of pro-inflammatory oxylipins and cytokines as circulating biomarkers in endometriosis\u2013a targeted \u2018omics study\u2019","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmig.2026.06.015_bib0124","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3892\/etm.2017.4794","article-title":"Circulating and peritoneal fluid interleukin-6 levels and gene expression in pelvic endometriosis","volume":"14","author":"De Andrade","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/2284026518779861","article-title":"Serum interleukin 6 and cancer antigen 125 in the non-invasive diagnosis of endometriosis","volume":"10","author":"Tanmahasamut","year":"2018","journal-title":"J Endometr Pelvic Pain Disord"},{"key":"10.1016\/j.jmig.2026.06.015_bib0126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2018.10.011","article-title":"The involvement of multifunctional TGF-\u03b2 and related cytokines in pathogenesis of endometriosis","volume":"201","author":"Sikora","year":"2018","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jmig.2026.06.015_bib0127","article-title":"Serum miR-17, IL-4, and IL-6 levels for diagnosis of endometriosis","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jmig.2026.06.015_bib0128","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/09513590.2017.1409717","article-title":"Expression of inflammatory cytokines in serum and peritoneal fluid from patients with different stages of endometriosis","volume":"34","author":"Fan","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0129","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12857","article-title":"Vasoactive intestinal peptide is upregulated in women with endometriosis and chronic pelvic pain","volume":"80","author":"Bourlev","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ijgo.12392","article-title":"Diagnostic accuracy of serum miR-122 and miR-199a in women with endometriosis","volume":"141","author":"Maged","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jmig.2026.06.015_bib0131","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52899-8","article-title":"Multiplex analysis of 40 cytokines do not allow separation between endometriosis patients and controls","volume":"9","author":"Knific","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmig.2026.06.015_bib0132","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13149","article-title":"Elevated serum interleukin-32 levels in patients with endometriosis: a cross-sectional study","volume":"82","author":"Choi","year":"2019","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0133","first-page":"4635","article-title":"Effects of gene polymorphism and serum levels of IL-2 and IL-6 on endometriosis","volume":"24","author":"Wang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jmig.2026.06.015_bib0134","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3343\/alm.2020.40.5.390","article-title":"Cytokines, angiogenesis, and extracellular matrix degradation are augmented by oxidative stress in endometriosis","volume":"40","author":"Nanda","year":"2020","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2021.102153","article-title":"Evaluation of Toll-like receptor 3 (TLR3) signaling pathway genes and its genetic polymorphisms in ectopic and eutopic endometrium of women with endometriosis","volume":"50","author":"Almasi","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.jmig.2026.06.015_bib0136","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/jog.14654","article-title":"Application of serum markers in diagnosis and staging of ovarian endometriosis","volume":"47","author":"Tang","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.jmig.2026.06.015_bib0137","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3390\/biomedicines9111681","article-title":"Exploring epithelial\u2013mesenchymal transition signals in endometriosis diagnosis and in vitro fertilization outcomes","volume":"9","author":"Cela","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jmig.2026.06.015_bib0138","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.3390\/ijms22052295","article-title":"Diagnostic significance of selected serum inflammatory markers in women with advanced endometriosis","volume":"22","author":"Kokot","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmig.2026.06.015_bib0139","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3889\/aph.2022.6060","article-title":"The role of some inflammatory markers, cytokins and tumor markers in diagnosis of endometriosis","volume":"14","author":"Georgievska","year":"2022","journal-title":"Arch Pub Health"},{"key":"10.1016\/j.jmig.2026.06.015_bib0140","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/pm\/pnad080","article-title":"IL-8 and IL-12p70 are associated with pelvic pain among infertile women with endometriosis","volume":"24","author":"Rahmawati","year":"2023","journal-title":"Pain Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0141","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1144323","article-title":"Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: a randomized, triple-blind placebo-controlled clinical trial","volume":"14","author":"Rostami","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jmig.2026.06.015_bib0142","doi-asserted-by":"crossref","DOI":"10.1080\/09513590.2023.2217290","article-title":"Evaluation of new biomarkers in stage III and IV endometriosis","volume":"39","author":"Kovalak","year":"2023","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jmig.2026.06.015_bib0143","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3329\/bjms.v23i1.70697","article-title":"Determination of cytokines for assessment of inflammatory status at genital endometriosis","volume":"23","author":"Appazova","year":"2024","journal-title":"Bangladesh J Med Sci"},{"key":"10.1016\/j.jmig.2026.06.015_bib0144","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.21608\/ejhm.2024.354963","article-title":"Interleukin-6 concentration in peritoneal fluid and serum of patients with and without endometriosis","volume":"95","author":"El-Adawy","year":"2024","journal-title":"Egypt J Hosp Med"},{"key":"10.1016\/j.jmig.2026.06.015_bib0145","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.3390\/ijms26115117","article-title":"Evaluation of proinflammatory cytokines concentrations in plasma, peritoneal, and endometrioma fluids in women operated on for ovarian endometriosis\u2014a pilot study","volume":"26","author":"W\u00f3jtowicz","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmig.2026.06.015_bib0146","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2025.108663","article-title":"Laparoscopically confirmed endometriosis and midlife plasma markers of inflammation, cholesterol, and adipokines among participants in the Nurses\u2019 Health Study II","volume":"200","author":"Farland","year":"2025","journal-title":"Maturitas"},{"key":"10.1016\/j.jmig.2026.06.015_bib0147","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-05719-1","article-title":"Evaluation of inflammatory serum parameters as a diagnostic tool in patients with endometriosis: a case-control study","volume":"15","author":"Kasoha","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmig.2026.06.015_bib0148","first-page":"1","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2020","journal-title":"Res Syn Meth"}],"container-title":["Journal of Minimally Invasive Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465026003274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553465026003274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:10:56Z","timestamp":1791501056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553465026003274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":148,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1553465026003274"],"URL":"https:\/\/doi.org\/10.1016\/j.jmig.2026.06.015","relation":{},"ISSN":["1553-4650"],"issn-type":[{"value":"1553-4650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Interleukin-6 Levels in Endometriosis and Endometriosis-Associated Ovarian Cancer: A Systematic Review and Meta-Analysis Demonstrating a Biological Gradient","name":"articletitle","label":"Article Title"},{"value":"Journal of Minimally Invasive Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmig.2026.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AAGL. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}